- A 58-year-old male with a history of type 2 diabetes and chronic obstructive pulmonary disease (COPD) presents with an acute exacerbation. He is treated with nebulized albuterol. One hour later, a point-of-care blood glucose measurement is significantly elevated. This metabolic side effect is primarily mediated by the stimulation of which adrenergic receptor?
Answer: β2-receptors in the liver and skeletal muscle, which promotes glycogenolysis.
Albuterol is a selective β2-agonist. Stimulation of β2-adrenergic receptors in the liver and skeletal muscle activates adenylyl cyclase, increases cAMP, and promotes glycogenolysis (breakdown of glycogen to glucose), leading to hyperglycemia. While α2-agonism can inhibit insulin secretion and β1-agonism can stimulate glucagon release, the primary mechanism for hyperglycemia from a β2-agonist is increased glucose production via glycogenolysis.
- A 65-year-old woman is prescribed mirabegron for symptoms of overactive bladder. This medication alleviates urinary urgency and frequency by promoting relaxation of the detrusor muscle. This therapeutic effect is mediated by agonism at which of the following receptors?
Answer: β3-adrenergic receptors
Mirabegron is a selective β3-adrenergic receptor agonist. The β3-receptors are highly expressed on the detrusor muscle of the urinary bladder. Stimulation of these receptors leads to smooth muscle relaxation, which increases bladder capacity and reduces the symptoms of overactive bladder. Agonism at α1-receptors would contract the bladder neck, while antagonism of M3 receptors is another strategy to relax the detrusor muscle.
- A patient in the intensive care unit for septic shock develops oliguria despite adequate fluid resuscitation. A low-dose infusion of an adrenergic agonist is initiated specifically to improve renal perfusion by causing selective vasodilation of the renal arteries. This targeted effect is mediated primarily by agonist activity at which receptor?
Answer: Dopamine D1 receptors in the renal vasculature.
At low doses, dopamine is unique among catecholamines for its ability to selectively activate D1 receptors, which are prominent in the renal, mesenteric, and coronary vascular beds. Activation of D1 receptors in the kidney leads to vasodilation, increasing renal blood flow and promoting natriuresis. This is the principle behind the use of 'renal-dose' dopamine, though its clinical utility is debated. β2 agonism can cause vasodilation, but it is not the primary mechanism for this specific indication. α1 agonism would cause vasoconstriction, and β1 agonism would primarily affect renin release.
- In the management of distributive shock, norepinephrine is often chosen over epinephrine as the first-line vasopressor. A key pharmacological reason for this preference is that, at typical therapeutic doses, norepinephrine:
Answer: has significantly less β2-agonist activity, resulting in more reliable vasoconstriction.
Both norepinephrine and epinephrine are potent α1 and β1 agonists. However, epinephrine also has significant β2-agonist activity, which causes vasodilation in certain vascular beds (like skeletal muscle). This can counteract its α1-mediated vasoconstriction and can sometimes lower diastolic pressure. Norepinephrine has very weak β2 activity. Therefore, it produces more consistent and powerful vasoconstriction, making it a more reliable agent for raising mean arterial pressure in distributive shock. The β2 activity of epinephrine can also increase lactate levels, which can complicate clinical assessment.
- A patient with a history of hypertension controlled with propranolol is brought to the emergency department for an anaphylactic reaction to a bee sting. They are given a standard dose of intramuscular epinephrine. Which of the following hemodynamic responses is most likely to occur in this patient?
Answer: A marked increase in blood pressure accompanied by reflex bradycardia.
Propranolol is a non-selective β-blocker, blocking both β1 and β2 receptors. When epinephrine is administered, its β-adrenergic effects are blocked. However, its α1-adrenergic effects (vasoconstriction) are not blocked and are therefore 'unopposed'. This leads to a severe increase in peripheral resistance and blood pressure. The β1-mediated tachycardia is blocked, and the profound hypertension triggers a strong baroreceptor reflex, resulting in significant reflex bradycardia. This is a classic and dangerous drug interaction.
- A patient uses an over-the-counter oxymetazoline nasal spray for 10 consecutive days to manage allergic rhinitis. They report that while the spray was initially effective, their nasal congestion is now worse than before, even immediately after use. This phenomenon of rhinitis medicamentosa is best explained by which of the following cellular mechanisms?
Answer: Downregulation and internalization of postsynaptic α1-adrenergic receptors.
Oxymetazoline is a direct-acting α1-adrenergic agonist. Prolonged or excessive stimulation of these receptors leads to a compensatory downregulation and internalization of the receptors, a form of homologous desensitization. This reduces the tissue's responsiveness to the drug, causing tachyphylaxis and rebound congestion. Depletion of norepinephrine stores is the mechanism of tachyphylaxis for indirect-acting agonists like ephedrine or amphetamine. The other options describe incorrect or less likely mechanisms.
- A 70-year-old patient is admitted with acute decompensated heart failure, presenting with a low cardiac index and elevated pulmonary capillary wedge pressure ('cold and wet' profile). An infusion of dobutamine is initiated. The primary therapeutic goal of dobutamine in this clinical scenario is to:
Answer: Improve myocardial contractility and cardiac output via β1-receptor stimulation.
When you encounter heart failure scenarios on pharmacology exams, focus on matching the drug's mechanism to the patient's specific hemodynamic profile. This patient has a "cold and wet" presentation—poor perfusion (low cardiac index) with fluid overload (elevated pulmonary capillary wedge pressure)—requiring an agent that primarily improves contractility.
Dobutamine is a synthetic catecholamine with predominant β1-adrenergic receptor activity. When it binds to β1-receptors in cardiac muscle, it activates adenylyl cyclase, increasing intracellular cAMP and ultimately enhancing calcium availability during systole. This positive inotropic effect directly addresses the underlying problem: inadequate myocardial contractility leading to poor cardiac output. The improved contractility helps pump blood more effectively, reducing venous congestion while increasing forward flow.
Answer B is incorrect because dobutamine has minimal direct diuretic properties—any diuresis occurs secondarily to improved cardiac output and renal perfusion. Answer C represents the opposite of dobutamine's vascular effects; it actually causes mild vasodilation through β2-receptor stimulation, reducing afterload. Answer D confuses dobutamine with negative chronotropic agents like beta-blockers—dobutamine typically increases heart rate through β1-stimulation, though this is generally outweighed by its beneficial inotropic effects.
Remember this pattern: in acute decompensated heart failure with poor contractility, think positive inotropes first. Dobutamine = β1-stimulation = increased contractility and cardiac output. This mechanism directly targets the pathophysiology rather than just treating symptoms.
- A patient taking an over-the-counter oral decongestant containing pseudoephedrine presents with palpitations and a blood pressure of 160/95 mmHg. The cardiovascular effects of this agent are best explained by which combination of mechanisms?
Answer: Direct stimulation of adrenergic receptors and promotion of endogenous norepinephrine release.
Pseudoephedrine is a mixed-acting adrenergic agonist. This means it exerts its effects through two primary mechanisms: 1) directly stimulating α- and β-adrenergic receptors, and 2) indirectly acting by causing the release of endogenous norepinephrine from presynaptic nerve terminals. This dual action leads to its cardiovascular side effects, including vasoconstriction (hypertension) and increased heart rate/contractility (palpitations).
- A patient with resistant hypertension is prescribed a medication that effectively lowers blood pressure but also causes significant drowsiness and dry mouth. The therapeutic antihypertensive effect of this drug is primarily mediated by its action as an agonist at which of the following sites?
Answer: Presynaptic α2-receptors in the nucleus tractus solitarii.
The clinical profile described (antihypertensive effect with sedation and dry mouth) is characteristic of a centrally-acting α2-agonist like clonidine or guanfacine. These drugs act on presynaptic α2-autoreceptors in the brainstem (specifically, the nucleus tractus solitarii), which inhibits sympathetic outflow from the central nervous system, leading to decreased blood pressure. The side effects are also centrally mediated. The other options describe targets for different classes of antihypertensive or vasoactive drugs.
- A healthy volunteer is administered a continuous intravenous infusion of phenylephrine. Assuming a normal and intact baroreceptor reflex, what are the expected net effects on mean arterial pressure (MAP) and heart rate (HR)?
Answer: Increased MAP and decreased HR.
Phenylephrine is a selective α1-adrenergic agonist. Its primary effect is potent vasoconstriction, leading to a significant increase in systemic vascular resistance and, consequently, mean arterial pressure (MAP). This sharp rise in MAP is sensed by baroreceptors in the carotid sinus and aortic arch. The baroreceptor reflex is then activated, leading to increased parasympathetic (vagal) outflow to the heart and decreased sympathetic tone, which results in a compensatory decrease in heart rate (reflex bradycardia).
- In an anesthetized animal, intravenous administration of prazosin, an α1-adrenergic antagonist, is followed by a dose of epinephrine. Which of the following effects on mean arterial pressure is expected?
Answer: A monophasic depressor response (a decrease in blood pressure).
When you encounter questions about adrenergic antagonists followed by agonist administration, think about which receptors remain available and what physiological effects will dominate.
Prazosin selectively blocks α1-adrenergic receptors, which mediate vasoconstriction. When epinephrine is administered after prazosin pretreatment, it can only activate the unblocked receptors: β1-receptors (increasing heart rate and contractility) and β2-receptors (causing vasodilation). Since α1-mediated vasoconstriction is blocked, epinephrine's β2-vasodilatory effects predominate in peripheral vessels, leading to decreased peripheral resistance and reduced mean arterial pressure. This creates a pure depressor response.
Let's examine why the other options are incorrect:
Option B describes a biphasic response, but this occurs with non-selective α-antagonists like phentolamine, not selective α1-antagonists like prazosin. There's no initial pressor phase because α1-mediated vasoconstriction is completely blocked from the start.
Option C suggests enhanced pressor effects, which is impossible since prazosin eliminates epinephrine's primary pressor mechanism (α1-vasoconstriction) while leaving vasodilatory β2-effects intact.
Option D incorrectly assumes complete receptor blockade. Prazosin only blocks α1-receptors; β-adrenergic receptors remain fully functional and responsive to epinephrine.
Study tip: Remember the concept of "epinephrine reversal" - when α1-receptors are blocked, epinephrine's effects reverse from predominantly pressor (vasoconstriction) to predominantly depressor (β2-vasodilation). This is a classic pharmacology principle that appears frequently on exams.
- A patient being treated with oral terbutaline to prevent preterm labor complains of a fine, bothersome tremor in her hands. This common side effect is a direct result of the drug's agonist activity on which of the following?
Answer: β2-receptors in skeletal muscle fibers
Terbutaline is a β2-adrenergic agonist. While its therapeutic effect in preterm labor is due to β2-receptor stimulation in the uterine smooth muscle (causing relaxation), the drug also stimulates β2-receptors located on skeletal muscle. This activation enhances the physiological tremor, leading to the fine tremor commonly seen as a side effect. Stimulation of β1-receptors would cause tachycardia. The other options describe incorrect receptor targets or locations for this effect.
- A patient in cardiogenic shock is treated with a continuous intravenous infusion of an adrenergic agonist. Hemodynamic monitoring shows a significant increase in cardiac output and heart rate, accompanied by a decrease in systemic vascular resistance. Which of the following agents was most likely administered?
Answer: Isoproterenol
The observed effects are a marked increase in heart rate and cardiac output (β1 effect) and a decrease in systemic vascular resistance (β2 effect). Isoproterenol is a non-selective β-agonist with potent activity at both β1 and β2 receptors, matching this profile perfectly. Norepinephrine has strong α1 and β1 activity, which would increase SVR. Phenylephrine is a pure α1-agonist, which would increase SVR and cause reflex bradycardia. Dobutamine is primarily a β1-agonist with weaker β2 activity, and it would be less likely to cause a significant drop in SVR compared to isoproterenol.
- To facilitate a funduscopic examination, an ophthalmologist administers eye drops that produce effective mydriasis (pupil dilation) with minimal cycloplegia (paralysis of accommodation). This pharmacological profile is characteristic of a drug that selectively stimulates which of the following receptors?
Answer: α1-adrenergic receptors on the pupillary dilator muscle.
Mydriasis without significant cycloplegia is achieved by stimulating the α1-adrenergic receptors on the radial (pupillary dilator) muscle of the iris. This contracts the muscle and dilates the pupil. Phenylephrine is a classic example of such a drug. In contrast, antimuscarinic drugs (which block M3 receptors) cause mydriasis by relaxing the pupillary constrictor muscle but also cause cycloplegia by relaxing the ciliary muscle. β2-receptors are primarily involved in aqueous humor production, not pupillary control.
- In an experimental preparation, the sympathetic nerve terminals innervating a rabbit heart are depleted of their endogenous catecholamines by pretreatment with reserpine. The subsequent administration of which of the following drugs would result in a significantly blunted chronotropic (heart rate) response compared to an untreated animal?
Answer: Amphetamine
Amphetamine is an indirect-acting sympathomimetic amine. Its primary mechanism of action is to promote the release of endogenous norepinephrine from presynaptic nerve terminals. Reserpine depletes these terminals of norepinephrine. Therefore, in a reserpine-pretreated animal, amphetamine has no norepinephrine to release and its effects will be severely blunted. In contrast, norepinephrine, isoproterenol, and dobutamine are all direct-acting agonists that stimulate adrenergic receptors directly and would still be effective in this preparation.
- A patient presents with anaphylactic shock, exhibiting severe hypotension and bronchoconstriction. Epinephrine is the drug of choice. Its superiority over a pure α-agonist like phenylephrine in this setting is primarily due to epinephrine's potent agonist activity at which receptor?
Answer: β2-receptors
When you encounter anaphylactic shock questions, think about the dual pathophysiology: severe vasodilation causing hypotension AND bronchoconstriction causing respiratory distress. The ideal treatment must address both problems simultaneously.
Epinephrine's superiority over pure α-agonists like phenylephrine lies in its ability to activate β2-receptors. β2-receptor stimulation causes powerful bronchodilation by relaxing smooth muscle in the airways, directly counteracting the life-threatening bronchoconstriction seen in anaphylaxis. While phenylephrine can address hypotension through α1-mediated vasoconstriction, it cannot reverse the airway obstruction that makes anaphylaxis so deadly.
Let's examine why the other options fall short: (A) α1-receptors cause vasoconstriction and help with hypotension, but phenylephrine is actually a potent α1-agonist, so this doesn't explain epinephrine's superiority. (B) β1-receptors provide positive inotropic and chronotropic effects that help cardiac output, but this alone wouldn't make epinephrine superior to phenylephrine for treating hypotension. (C) D1-receptors are dopamine receptors involved in renal vasodilation and aren't relevant to epinephrine's mechanism in anaphylaxis.
The correct answer is (D) β2-receptors because bronchodilation is the unique advantage epinephrine provides over pure α-agonists.
Study tip: Remember "β2 = breathing" - β2-receptors are your go-to for bronchodilation. In anaphylaxis questions, always consider that successful treatment requires addressing both cardiovascular collapse AND airway obstruction, making epinephrine's dual α/β activity essential.
- A 9-year-old child is prescribed extended-release guanfacine for attention-deficit/hyperactivity disorder (ADHD). The medication is found to improve working memory and reduce distractibility. This therapeutic effect is primarily attributed to the stimulation of which receptors in the prefrontal cortex?
Answer: Postsynaptic α2A-adrenergic receptors, which strengthen network connectivity.
Guanfacine is a selective α2A-adrenergic agonist. In the context of ADHD, its therapeutic effects are not due to the antihypertensive mechanism in the brainstem, but rather its action on postsynaptic α2A-receptors in the prefrontal cortex (PFC). Stimulation of these receptors is thought to strengthen synaptic connections and improve the signal-to-noise ratio of PFC neuronal networks, which enhances executive functions like working memory and attention regulation. While dopamine is also crucial for PFC function, guanfacine's primary target is the α2A-receptor.
- A patient with poorly controlled asthma frequently uses their albuterol inhaler. Over time, they experience a diminished bronchodilator response to the drug. The most likely molecular mechanism underlying this acquired tolerance involves which of the following processes?
Answer: Phosphorylation of the intracellular domain of the β2-receptor, promoting its uncoupling from Gs protein.
This phenomenon is known as tachyphylaxis or desensitization. With repeated or prolonged exposure to an agonist like albuterol, the β2-adrenergic receptor becomes phosphorylated by kinases such as β-adrenergic receptor kinase (BARK) or protein kinase A. This phosphorylation promotes the binding of a protein called β-arrestin to the receptor, which sterically hinders its interaction with its Gs protein, effectively uncoupling it from the downstream signaling pathway (adenylyl cyclase/cAMP). This leads to a diminished cellular and clinical response.
- The administration of an adrenergic agonist causes contraction of vascular smooth muscle. The intracellular signaling cascade responsible for this effect involves G-protein-mediated activation of phospholipase C, which in turn generates the second messengers inositol trisphosphate (IP3) and diacylglycerol (DAG). This entire pathway is initiated by the binding of the agonist to which receptor subtype?
Answer: α1-adrenergic
The α1-adrenergic receptor is coupled to the Gq protein. Activation of Gq stimulates phospholipase C (PLC). PLC cleaves phosphatidylinositol 4,5-bisphosphate (PIP2) into inositol trisphosphate (IP3) and diacylglycerol (DAG). IP3 triggers the release of Ca2+ from intracellular stores, and DAG activates protein kinase C, both of which contribute to smooth muscle contraction. β receptors are Gs-coupled (activating adenylyl cyclase), and α2 receptors are Gi-coupled (inhibiting adenylyl cyclase).
